Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05967806 · ClinicalTrials.gov registry record

A Study to Identify and Characterise Patients With Chronic Kidney Disease and Proteinuria

A clinical trial of Renal Disease, sponsored by AstraZeneca.

Completed
Registry status
2,575
Enrollment target
20
Study locations

NCT05967806 is a study of Renal Disease that has completed, run by AstraZeneca. The registered enrollment target is 2,575 participants, below the 195,636-participant average among 4 other Renal Disease trials with a reported enrollment target (99% lower). The trial reports 20 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05967806, a study of Renal Disease, has completed, sponsored by AstraZeneca.

COMPLETED
Registry status
2,575 participants
Enrollment target
20
Study locations

Study Summary

The purpose of the D4325C00007 study is to identify and characterise patients with known or newly diagnosed CKD for possible participation in future renal clinical studies and to obtain an overview on current treatment choices for this patient group in different regions.

Conditions Studied

Renal Disease

Interventions

  • PROCEDURE assessment

Study Locations (20)

California

  • Research Site - Bakersfield
  • Research Site - Chatsworth
  • Research Site - San Carlos
  • Research Site - South Gate
  • Research Site - Tarzana
  • Research Site - Victorville

North Carolina

  • Research Site - Kinston
  • Research Site - New Bern
  • Research Site - Wilmington
  • Research Site - Winston-Salem

Other

  • Research Site - Buenos Aires
  • Research Site - Santa Fe
  • Research Site - Belém

Florida

  • Research Site - Jacksonville
  • Research Site - Miami

Texas

  • Research Site - Pearland
  • Research Site - San Antonio

Alabama

  • Research Site - Huntsville

South Carolina

  • Research Site - Greenville

Virginia

  • Research Site - Arlington

Trial Details

FieldValue
Enrollment Target 2,575 participants
Start Date 2023-07-31
Est. Completion 2024-08-30

Sponsor

AstraZeneca

1,285 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05967806

The ClinicalTrials.gov registry entry for NCT05967806 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,575 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 195,636-participant average among 4 other Renal Disease trials with a reported enrollment target (99% lower). The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Renal Disease appearing as the primary indexed condition, and to 1 intervention - of which assessment is the first listed.

NCT05967806 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, North Carolina, Other.

Frequently Asked Questions

What is clinical trial NCT05967806 about?

NCT05967806 is a clinical study titled "A Study to Identify and Characterise Patients With Chronic Kidney Disease and Proteinuria". The purpose of the D4325C00007 study is to identify and characterise patients with known or newly diagnosed CKD for possible participation in future renal clinical studies and to obtain an overview on current treatment choices for this patient group in different regions.

What is the current status of trial NCT05967806?

This trial is currently completed. The enrollment target is 2,575 participants. The study started on 2023-07-31. Estimated completion is 2024-08-30.

What conditions does trial NCT05967806 study?

This clinical trial studies the following conditions: Renal Disease.

What interventions are being tested in trial NCT05967806?

The interventions under investigation include: assessment (PROCEDURE).

Who is sponsoring clinical trial NCT05967806?

This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05967806 being conducted?

This trial has 20 study locations across Alabama, California, Florida, North Carolina, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Renal Disease

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.